Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury. (Q54116747)

25 May 2018

title

Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury. (English)

1 reference

25 May 2018

main subject

pulmonary hypertension

1 reference

Jacobs BR

1

1 reference

25 May 2018

Brilli RJ

2

1 reference

25 May 2018

Ballard ET

3

1 reference

25 May 2018

Passerini DJ

4

1 reference

25 May 2018

Smith DJ

5

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

25 May 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

25 May 2018

volume

158

1 reference

25 May 2018

issue

5 Pt 1

1 reference

25 May 2018

page(s)

1536-1542

1 reference

25 May 2018

The incidence of the adult respiratory distress syndrome

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

Adult respiratory distress syndrome--how many cases in the UK?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

Predicting death in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. Extracorporeal Life Support Organization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

Mortality rates and prognostic variables in children with adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

Endoscopic laser third ventriculostomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

Aerosolization of novel nitric oxide donors selectively reduce pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome: dose response, prolonged inhalation, and weaning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

Nitrogen dioxide production during mechanical ventilation with nitric oxide in adults. Effects of ventilator internal volume, air versus nitrogen dilution, minute ventilation, and inspired oxygen fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

Delayed effects of NO2 exposure on alveolar permeability and glutathione peroxidase in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.5.9802114

10.1164/AJRCCM.158.5.9802114

21 January 2018

Identifiers

DOI

1 reference

25 May 2018

release_upfmw5uyznhaxlw2thr47tvj6e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/upfmw5uyznhaxlw2thr47tvj6e

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9817705

1 reference

25 May 2018